Vivimed Labs scales record high as HNI investor buys shares

Vivimed Labs jumped 6.14% at Rs 108.95 at 11:11 IST on BSE after Ashish Kacholia bought 13.73 lakh shares in the company in a bulk deal on NSE yesterday, 27 September 2016.

Meanwhile, the S&P BSE Sensex was up 5.69 points, or 0.02%, to 28,229.39

On BSE, so far 17.28 lakh shares were traded in the counter, compared with average daily volume of 1.12 lakh shares in the past one quarter. The stock hit a high of Rs 114.80 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 106 so far during the day. The stock hit a 52-week low of Rs 58.40 on 28 September 2015. The stock had outperformed the market over the past 30 days till 27 September 2016, rising 38.53% compared with 1.15% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 33.4% as against Sensex's 5.55% rise.

 

The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 2.

High-net-worth individual (HNI) investor Ashish Kacholia bought 13.73 lakh shares of Vivimed Labs at Rs 90.50 per share in a bulk deal on NSE yesterday, 27 September 2016. Shares of Vivimed Labs gained by its maximum permissible daily limit of 20% to settle at Rs 102.65 yesterday, 27 September 2016.

On a consolidated basis, Vivimed Labs' net profit rose 15.27% to Rs 27.86 crore on 10.65% growth in net sales to Rs 366.83 crore in Q1 June 2016 over Q1 June 2015.

Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.

Powered by Capital Market - Live News